Microsoft on Monday, Oct. 26, introduced a time-limited Voluntary Exit Offer that lets eligible employees in participating parts of the company leave with financial support, and the company confirmed to the trade publication CRN that about 60,000 employees are eligible.
EyePoint, a Watertown, Massachusetts, drug developer focused on retinal diseases, plans to cut about 53% of its workforce after a pivotal trial of its lead drug candidate in wet age-related macular degeneration missed its primary goal. The company announced the plan Monday, Oct.
